Effect of Interferon-gamma 1-b on Innate Immune Cells
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Chronic granulomatous disease
- Focus Pharmacodynamics
- 11 Dec 2017 Planned End Date changed from 1 Nov 2017 to 1 Feb 2018.
- 11 Dec 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Feb 2018.
- 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.